Enhanced Therapeutic Effects of (177)Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts

SIMPLE SUMMARY: Cancer treatment is hampered by the limitations of individual therapy modalities and the intricate nature of the disease. The administration of maximal monotherapy doses often leads to undesirable side effects and/or therapy resistance. As a result, there is a growing recognition of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohajershojai, Tabassom, Spangler, Douglas, Chopra, Saloni, Frejd, Fredrik Y., Yazaki, Paul J., Nestor, Marika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486833/
https://www.ncbi.nlm.nih.gov/pubmed/37686514
http://dx.doi.org/10.3390/cancers15174239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486833/
https://www.ncbi.nlm.nih.gov/pubmed/37686514
http://dx.doi.org/10.3390/cancers15174239

Ejemplares similares